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Extracellular Double-Stranded RNA Induces
TSLP via an Endosomal Acidification- and
NF-jB-Dependent Pathway in Human Keratinocytes
Anh T. Vu1,2,3,5, Xue Chen1,4,5, Yang Xie1,5, Seiji Kamijo1, Hiroko Ushio1, Junko Kawasaki1,2,
Mutsuko Hara1, Shigaku Ikeda1,2, Ko Okumura1, Hideoki Ogawa1 and Toshiro Takai1
Double-stranded RNA (dsRNA) causes keratinocytes to release thymic stromal lymphopoietin (TSLP), which
plays a key role in allergic diseases. Endosomal Toll-like receptor 3 (TLR3) and cytosolic RIG-like receptors (RLRs)
and PKR have been reported to recognize dsRNA. Here, we demonstrate that dsRNA induces TSLP in
keratinocytes via an endosomal acidification-dependent and NF-kB-mediated pathway. After treatment with
pharmacologic inhibitors or transfection with small interfering RNAs (siRNAs), primary human keratinocytes
were stimulated. Bafilomycin A1, which inhibits endosomal acidification to block the TLR3 pathway, blocked the
dsRNA-induced expression of TSLP, IL-8, IFN-b, and other molecules including the dsRNA sensors, whereas it
did not inhibit diacyllipopeptide-induced expression of TSLP and IL-8. The dsRNA-induced gene expression of
TSLP depended on RelA, a component of NF-kB, but not IRF3, similar to IL-8 but different from IFN-b, which
depended on both IRF3 and RelA. The results indicate that endosomal acidification and the subsequent
activation of NF-kB are necessary to sense extracellular dsRNA, suggesting the importance of the TLR3–NF-kB
axis to trigger production of TSLP against the self dsRNA released from damaged cells or viral dsRNA, in the
epidermis, relating to skin inflammation including atopic dermatitis (AD).
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INTRODUCTION
Thymic stromal lymphopoietin (TSLP), highly expressed by
keratinocytes in the lesions of atopic dermatitis (AD) patients
and by bronchial epithelial cells in asthma patients (Soumelis
et al., 2002), plays a key role in allergic diseases (Liu, 2006;
Holgate, 2007). TSLP-activated dendritic cells secrete T
helper 2 (Th2)-recruiting chemokines but not IL-12, and
cause naive T cells to differentiate into inflammatory Th2
cells producing IL-4, IL-5, IL-13, and tumor necrosis factor-a
through the OX40 ligand. TSLP similarly activates epidermal
Langerhans cells, a subset of dendritic cells (Ebner et al.,
2007). The TSLP-activated dendritic cells can cause allergen-
specific Th2 memory cells to undergo homeostatic expansion
and further Th2 polarization and to mediate recall responses.
TSLP can also directly act on human mast cells (Allakhverdi
et al., 2007), human activated CD4þ T cells (Rochman et al.,
2007), human eosinophils (Wong et al., 2010), and human
invariant natural killer T cells (Wu et al., 2010). Thus, TSLP
represents a critical factor linking responses at interfaces
between the body and environment to allergic type 2
immune responses.
Recently, we demonstrated that a synthetic double-
stranded RNA (dsRNA), polyinosinic-polycytidylic acid
(poly(IC)), triggers the release of TSLP in primary human
keratinocytes and induces the gene expression of various
proinflammatory molecules along with TSLP (Kinoshita et al.,
2009; Le et al., 2009, 2010). At least four molecules, Toll-like
receptor 3 (TLR3), retinoid-inducible gene I (RIG-I), melano-
ma differentiation antigen 5 (MDA5), and IFN-inducible
double-stranded RNA-activated protein kinase (PKR), can
recognize dsRNA (Matsumoto and Seya, 2008; McAllister
and Samuel, 2009; Takeuchi and Akira, 2010). TLR3 is
located in endosomes and, in some types of cells, also on the
cell surface, whereas the other three dsRNA sensors, RIG-I,
MDA5, and PKR, are located in the cytosol. RIG-I and MDA5
structurally belong to the same pattern recognition molecule
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family, called RIG-like receptors (RLRs). The dsRNA sensors
survey viral invasion or infection by sensing viral dsRNA to
induce cellular responses (Matsumoto and Seya, 2008;
McAllister and Samuel, 2009; Takeuchi and Akira, 2010)
and, very recently, TLR3 has been suggested to sense self
dsRNA released from damaged cells to induce inflammation
(Cavassani et al., 2008; Lai et al., 2009).
Which dsRNA sensor(s) senses dsRNA to trigger the
production of TSLP in keratinocytes is unknown. Although
another research group addressed this issue using pharma-
cologic inhibitors and suggested a contribution of PKR and
RIG-I but not TLR3 to the dsRNA-induced TSLP expression
(Seidl et al., 2009), whether their experimental conditions are
suitable for the release of the TSLP protein is unknown as they
analyzed TSLP expression only at the mRNA level (Takai
et al., 2009). Here, we investigate which RNA sensor is
involved in the release of TSLP in keratinocytes stimulated
with extracellular dsRNA and show results contradicting
previous findings and conclusions.
RESULTS
The endosomal acidification inhibitor, bafilomycin A1 (BFA),
suppressed the dsRNA-induced release of TSLP in keratinocytes
Endosomal TLR3, two cytosolic RLRs (RIG-I and MDA5), and
cytosolic PKR have been reported to recognize dsRNA
(Matsumoto and Seya, 2008; McAllister and Samuel, 2009;
Takeuchi and Akira, 2010). BFA inhibits the acidification of
endosomes to block TLR3’s recognition of dsRNA in
endosomes (de Bouteiller et al., 2005; Huss and Wieczorek,
2009). The kinase activity of PKR is inhibited by
2-aminopurine (2AP) (Hu and Conway, 1993; Pereira et al.,
2010). BFA (100 nM) completely inhibited the release of
TSLP and IL-8 in keratinocytes stimulated with a synthetic
dsRNA, poly(IC), whereas 5mM 2AP did not inhibit TSLP
and partially inhibited IL-8 (Figure 1a). The results for BFA at
the protein level (Figure 1a) were supported by analysis at
the mRNA level showing that BFA completely inhibited the
poly(IC)-induced gene expression of cytokines (TSLP, IFN-b,
and IL-6) and chemokines (CXCL8/IL-8, CXCL10/INF-induci-
ble protein 10 (IP-10), and CCL5/regulated upon activation,
normal T-cell expressed, and secreted (RANTES)) (Figure 1b).
The results suggest that TLR3 is essential to the dsRNA-induced
responses including the production of TSLP in keratinocytes.
BFA did not suppress the diacylated lipopeptide-induced release
of TSLP in keratinocytes
Next, we examined whether 100 nM BFA and 5mM 2AP affect
the response of keratinocytes to other stimuli with no relation
to the dsRNA sensors (Figure 2). Very recently, we demon-
strated that a synthetic diacylated lipopeptide, FSL-1, and the
Staphylococcus aureus membrane fraction induced TSLP
production in keratinocytes via the TLR2–TLR6 pathway (Vu
et al., 2010). BFA did not inhibit the FSL-1-induced
expression of TSLP and IL-8 at either the protein (Figure 2a)
or mRNA (Figure 2b) level, consistent with TLR2 ligands
being recognized by TLR2 on the cell surface, but not in
endosomes (Takeuchi and Akira, 2010), in contrast to the
finding that BFA completely inhibited the poly(IC)-triggered
responses (Figures 1 and 2, Poly(IC)þBFA). BFA did not
inhibit the IL-1a-induced release of IL-8 either (Figure 2a,
250 100 600 250
200
150
100
0
50
1,50040
30
20
10
R
el
at
ive
 e
xp
re
ss
io
n
0
1,200
CCL5
(RANTES)
mRNA
CXCL10
(IP-10)
mRNA
CXCL8 (IL-8)
mRNA
CXCL8
(IL-8)
*
*
900
600
300
0
1,500
1,200
900
600
300
0
BF
A
BF
A
2A
P
2A
P
+ +
3 Hours 9 Hours
+ + + +
– –
– –
– –BF
A
BF
A
2A
P
2A
P
+ +
3 Hours 9 Hours
+ + + +
– –
– –
– –BF
A
BF
A
BF
A
2A
P
2A
P
2A
P
++ + +
InhibitorInhibitor
Poly(lC)Poly(lC) +
3 Hours 9 Hours
+ + + +
–––
–
–
– –
– –
500
400
300
200
100
0
80
TSLP
mRNA
IFN-β
mRNA
IL-6
mRNA
60
R
el
at
ive
 e
xp
re
ss
io
n
40
20
0
200
TSLP *
150
Se
cr
et
io
n 
(pg
 m
l–1
)
100
*
50
12,000
10,000
8,000
6,000
Se
cr
et
io
n 
(pg
 m
l–1
)
4,000
2,000
0
0
Figure 1. Bafilomycin A1 (BFA) blocked polyinosinic-polycytidylic acid (poly(IC))-induced expression of thymic stromal lymphopoietin (TSLP) in
keratinocytes. (a) Protein concentrations in the culture supernatant. *Po0.001 versus poly(IC) without the inhibitors by analysis of variance (ANOVA) with
Tukey’s multiple comparison test. (b) Levels of mRNA at 3 and 9 hours are presented relative to the medium at 3 hours. Data shown are the mean±SD for three
wells (a) and the values for single wells (b), and are representative of three independent experiments with similar results. Keratinocytes were treated with 100 nM
BFA or 5mM 2-aminopurine (2AP) before stimulation.
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lower, IL-1a). 2AP moderately enhanced the FSL-1-evoked
production of TSLP (Figure 2a, upper, FSL-1þ2AP).
Extracellular dsRNA induced gene expression of TSLP in a
manner dependent on RelA, a component of NF-jB, but not
IFN-regulatory factor 3 (IRF3) in keratinocytes
Cellular signaling through TLR3 or RLRs similarly results in
the activation of two transcription factors: NF-kB and IRF3
(Matsumoto and Seya, 2008; Takeuchi and Akira, 2010). We
asked which of NF-kB and IRF3 contributes to the dsRNA-
induced gene expression of TSLP. Transfection of keratino-
cytes with small interfering RNA (siRNA) for RelA, a
component of NF-kB, inhibited poly(IC)-induced gene
expression of TSLP (Figure 3a), IL-8 (Figure 3b), and IFN-b
(Figure 3c), and transfection with siRNA for IRF3 suppressed
IFN-b but not TSLP or IL-8 expression (Figure 3c). The results
suggest that the dsRNA-induced gene expression of TSLP
and IL-8 in keratinocytes depends on NF-kB rather than
IRF3, different from that of IFN-b, which depends on both
IRF3 and NF-kB.
BFA suppressed the dsRNA-induced release of TSLP in
keratinocytes most efficiently among three pharmacological
inhibitors for the dsRNA sensor pathways
TBK1 phosphorylates and activates IRF3 in a common
cascade downstream of both TLR3 and RLRs (Matsumoto
and Seya, 2008; Takeuchi and Akira, 2010). We examined
the effect of 5 mM SU6668, which inhibits the activity of
TANK-binding kinase 1 (TBK1) (Godl et al., 2005), on the
poly(IC)-induced TSLP expression (Figure 4a, left). SU6668
(5 mM) did not inhibit the poly(IC)-induced release of TSLP
(Figure 4a, right). BFA completely inhibited the release of
TSLP induced by not only 1 mgml–1 but also 20mgml–1
poly(IC) (Figure 4b).
BFA exhibited the inhibitory activity at concentrations
45–10 nM (Chen, Xie, and Takai, unpublished observations).
We examined the effect of 2AP and SU6668 at higher
concentrations than those applied by another research group
(5mM and 5 mM, respectively; Kalali et al., 2008; Seidl et al.,
2009); 10mM 2AP and 20 mM SU6668 partially inhibited the
release of TSLP and 20mM 2AP and 40 mM SU6668 inhibited
the majority of the release (Figure 4c).
As the manufacturer of poly(IC) is different between this
study (GE Healthcare/Amersham) and the reports by another
research group (InvivoGen) (Kalali et al., 2008; Seidl et al.,
2009), we examined the effect of the inhibitors on the release
of TSLP induced by poly(IC)s of InvivoGen (Figure 4d).
Currently, InvivoGen distributes two products of poly(IC)
with high and low molecular weights (1.5–8 and 0.2–1 kDa,
respectively; high and low molecular weights in Figure 4d).
BFA (100 or 20 nM) completely inhibited the release of
TSLP induced by poly(IC)s of InvivoGen (Figure 4d),
whereas 5mM 2AP and 5 mM SU6668 did not inhibit it and
did at some of the higher concentrations tested (Figure 4d,
high molecular weight, 45mM 2AP and 45 mM SU6668; low
molecular weight, 15 and 45mM 2AP and 15 and 45 mM
SU6668).
Expression levels of the dsRNA sensors in keratinocytes and
effect of the pharmacologic inhibitors on the expression
Stimulation with poly(IC) induced an upregulation of the
gene expression of the four dsRNA sensors (Figure 5a). The
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Figure 2. Bafilomycin A1 (BFA) did not inhibit FSL-1-induced expression of thymic stromal lymphopoietin (TSLP) in keratinocytes. (a) Protein concentrations
in the culture supernatant. Broken line shows the minimum detection limit. *Po0.001 versus the stimulation without the inhibitors by analysis of variance
(ANOVA) with Tukey’s multiple comparison test. (b) Levels of mRNA at 4, 6, and 8hours are presented relative to the medium at 4 hours. Data shown are the
mean±SD for three wells (a) and the values for single wells (b), and are representative of three independent experiments with similar results. Keratinocytes were
treated with 100 nM BFA or 5mM 2-aminopurine (2AP) before stimulation.
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relative level of mRNA (Figure 5a) and the increase caused by
poly(IC) (Figure 5a) were higher for the RLRs (RIG-I and
MDA5) than for TLR3 and PKR. Although TLR3 showed the
lowest mRNA expression among the four dsRNA sensors,
analysis by flow cytometry showed the intracellular protein
expression of TLR3 to be enhanced after the poly(IC)
stimulation (Figure 5b, Intracellular staining) and weak cell-
surface expression after the poly(IC) stimulation (Figure 5b,
Surface staining).
BFA (100 nM) inhibited the poly(IC)-induced gene expres-
sion of the dsRNA sensors (Figure 6a), whereas 5mM 2AP and
5 mM SU6668 showed no or partial inhibition of the poly(IC)-
induced gene expression of the dsRNA sensors (Chen, Xie,
and Takai, unpublished observations and Figure 6b).
DISCUSSION
In this study, we examined three pharmacologic compounds,
BFA, 2AP, and SU6668, which respectively inhibit the TLR3,
PKR, and TBK1 pathways, to investigate which RNA sensor is
involved in the dsRNA-induced production of TSLP in human
keratinocytes. The nucleic acid-sensing TLRs (TLR3, TLR7,
TLR8, and TLR9) recognize their ligands in endosomes, but
not on the cell surface (Takeuchi and Akira, 2010). TLR3 is the
endosomal dsRNA sensor (Matsumoto and Seya, 2008;
Takeuchi and Akira, 2010). BFA is an inhibitor of V-ATPases
(Huss and Wieczorek, 2009) and can inhibit acidification of
endosomes to block TLR3’s recognition of dsRNA (de
Bouteiller et al., 2005). 2AP inhibits the activity of kinases
including a cytosolic dsRNA sensor, PKR (Hu and Conway,
1993; Pereira et al., 2010). TLR3, using TRIF as an adapter
molecule, consequently activates two transcription factors:
NF-kB and IRF3. However, RLRs also activate NF-kB and IRF3
via mitochondrial IFN-b-promoter stimulator 1 (IPS-1, also
known as MAVS/VISA/Cardif). In a common cascade down-
stream of TLR3 and RLRs, TBK1 phosphorylates and activates
IRF3. SU6668 inhibits the activity of kinases including TBK1
(Godl et al., 2005). We demonstrated that BFA (100nM)
completely inhibited the dsRNA-induced responses in kera-
tinocytes (Figures 1, 2, 4, and 6). 2AP and SU6668 needed
much higher concentrations to exhibit complete suppression
of the dsRNA-induced release of TSLP than that applied by
another research group (Kalali et al., 2008; Seidl et al., 2009)
(Figure 4c and d); however, whether the inhibition at such
high concentrations of 2AP and SU6668 is critically because
of specific inhibition of PKR and TBK1, respectively, is
unknown. The dsRNA-induced gene expression of TSLP was
dependent on RelA, a component of NF-kB, rather than IRF3,
similarly to IL-8 (Figure 3a and b). The results suggest the
importance of the TLR3–NF-kB axis in the induction of TSLP
expression in keratinocytes stimulated with dsRNA. The
inhibition of IFN-b gene expression by transfection with
either siRNA for RelA or IRF3 (Figure 3c) is consistent with the
presence of binding sites for both NF-kB and IRF3 in the gene
promoter (Reily et al., 2006). In bronchial epithelial cells,
TLR3 has been reported to be responsible for poly(IC)-induced
proinflammatory responses including TSLP, depending on NF-
kB and/or IRF3 (Matsukura et al., 2006, 2007; Kato et al.,
2007), and IL-1b- and tumor necrosis factor-a-induced TSLP
TSLP mRNA (6 hours)
CXCL8 (IL-8)
mRNA (6 hours)
IFN-β mRNA (6 hours)
6,000 3,000
2,500
2,000
1,500
1,000
500
0
5,000
4,000
3,000
2,000
1,000
0
IFN-β mRNA (9 hours)
CXCL8 (IL-8)
mRNA (9 hours)
TSLP mRNA (9 hours)
70
60
80
70
60
50
40
30
20
10
0
50
–60%
–86%
–70%
–60%
–96%
–80%
–81%
–87%
40
30
R
el
at
ive
 e
xp
re
ss
io
n
R
el
at
ive
 e
xp
re
ss
io
n
20
10
0
70
60
50
40
30
R
el
at
ive
 e
xp
re
ss
io
n
20
10
0
siRNA
LA-MAX
Poly(lC)
+ + + + + +
+++
12
10
8
6
4
2
0
++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
+ + + + + +
+++++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
siRNA
LA-MAX
Poly(lC)
+ + + + + +
+++++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
+ + + + + +
+++++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
siRNA
LA-MAX
Poly(lC)
+ + + + + +
+++++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
+ + + + + +
+++++–
N
on
e
N
on
e
Co
nt
ro
l (L
)
Co
nt
ro
l (M
)
IR
F3
 (M
)
R
eI
A 
(L)
Figure 3. Transfection with RelA small interfering RNA (siRNA), but not
IFN-regulatory factor 3 (IRF3) siRNA, inhibited the polyinosinic-
polycytidylic acid poly(IC)-induced gene expression of thymic stromal
lymphopoietin (TSLP) in keratinocytes. Keratinocytes transfected with siRNAs
using LipofectamineRNAiMAX (LA-MAX) were stimulated with poly(IC).
Levels of mRNA at 6 and 9hours are presented relative to that without the
stimulation at 6 and 9hours, respectively. L and M represent 35–45% and
45–55% guanine-cytosine content, respectively. Results using RelA-siRNA2
and IRF3-siRNA3 are shown. Data shown are the values for single wells and
representative of three independent experiments including those using RelA
and IRF3 siRNAs with other sequences.
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promoter activation has been reported to be mediated by an
upstream NF-kB-binding site in the gene promoter of TSLP
(Lee and Ziegler, 2007).
Just before we began this study, another research group
reported an effect of pharmacologic inhibitors on poly(IC)-
induced IL-8 and IFN-b expression in keratinocytes
(Kalali et al., 2008). Later, corresponding to our publication
(Kinoshita et al., 2009), they reported additional data
concerning the induction of TSLP (Seidl et al., 2009).
However, our results in this study on TSLP are quite the
opposite of their results and conclusions. They suggested that
the poly(IC)-induced TSLP transcription in keratinocytes is
dependent on PKR and RIG-I but not TLR3 on the basis of the
finding that 5mM 2AP and 5 mM SU6668, but not 100 nM BFA,
almost completely inhibited poly(IC)-induced TSLP transcrip-
tion and that transfection with siRNAs for RIG-I or PKR
caused a 30–50% reduction (Seidl et al., 2009). The patterns
of inhibition of the transcription (Seidl et al., 2009) resemble
those for the transcription and release of IFN-b associated
with IRF-3 activation but not IL-8 associated with NF-kB
activation (Kalali et al., 2008), suggesting a contribution of
IRF3 to the dsRNA-induced TSLP transcription in keratino-
cytes (Seidl et al., 2009). In contrast, in our experimental
conditions, 100 nM BFA completely inhibited the poly(IC)-
induced expression of TSLP, IL-8, IFN-b, and other molecules
including the dsRNA sensors (Figures 1 and 6), but 5mM 2AP
and 5 mM SU6668 did not inhibit the poly(IC)-induced TSLP
expression (Figures 1 and 4), and a contribution of NF-kB
rather than IRF3 to the poly(IC)-induced TSLP gene expres-
sion was suggested (Figure 3a).
We have three major concerns regarding the report by
Seidl et al. (2009), which concluded little contribution of
TLR3 to the poly(IC)-induced gene expression of TSLP: first,
the release of TSLP protein should be measured; second,
negative control experiments to confirm that another
stimulation with no relation to the dsRNA sensors is not
inhibited by the inhibitors should be performed; and third,
TLR3 might contribute to the dsRNA-induced response in
keratinocytes under other experimental conditions (Takai
et al., 2009). In turn, in this study, we demonstrated that BFA
blocked poly(IC)-dependent TSLP expression at the mRNA
and protein levels (Figure 1) and that BFA did not inhibit
diacylated lipopeptide-dependent, TLR2–TLR6-mediated ex-
pression of TSLP and IL-8, and IL-1a-mediated IL-8 expres-
sion (Figure 2), suggesting that BFA can cancel specifically
the dsRNA-induced, endosomal TLR3-mediated responses
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wells and are representative of three (a–c) or two (d) independent experiments
with similar results.
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but cannot inhibit the responses mediated by nonendosomal
pathways. 2AP moderately enhanced the FSL-1-induced TSLP
expression (Figure 2, FSL-1) for unknown reasons.
There is a great discrepancy between their results
(Seidl et al. 2009) and ours in the effect of BFA on the
poly(IC)-induced TSLP expression (Figures 1, 2, and 4, TSLP).
The concentration and manufacture of poly(IC) are different
between their experiments (20 mgml–1, InvivoGen) (Kalali
et al., 2008; Seidl et al., 2009) and ours (1 mgml–1, GE
Healthcare/Amersham); however, BFA completely inhibited
the release of TSLP in keratinocytes stimulated with
20 mgml–1 poly(IC) purchased from both manufacturers
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(Figure 4b and d). Transfection of poly(IC) using transfection
reagents is known to stimulate cytosolic dsRNA sensors
(McAllister and Samuel, 2009); however, transfection of
poly(IC) using Lipofectamine2000 (Invitrogen) reduced the
TSLP expression (Vu and Takai, unpublished observations).
Although the cause of the discrepancy is unknown, it might
be because of differences in the culture conditions, differ-
entiation, or donors of keratinocytes, and so on. We cannot
exclude the possibility that poly(IC) without the aid of
transfection reagents more easily entered the cytosol under
their experimental conditions (Kalali et al., 2008; Seidl et al.,
2009) than ours and subsequently stimulated the cytosolic
sensors to activate NF-kB, and/or that cytosolic dsRNA
sensors take part in the production of TSLP in virus-infected
keratinocytes, in which viral replication in the cytosol could
supply abundant dsRNA to the cytosolic sensors.
To determine the contribution of each of the dsRNA
sensors more directly, we examined transfection with siRNAs
for not only the transcription factors (Figure 3) but also the
dsRNA sensors. However, the transfection of the dsRNA
sensor siRNAs did not inhibit the majority of the response
with sufficient reproducibility and clarity, affecting the
interpretation of the results (Vu and Takai, unpublished
observations). We assume that this is because of difficulty in
suppressing the dsRNA-induced upregulation of the sensor’s
expression with reproducibility to a sufficiently lower level
than before stimulation with dsRNA (Figure 5; and Vu and
Takai, unpublished data). Other researchers also reported
moderate or minor inhibition of dsRNA-induced TSLP gene
expression on transfection with siRNAs for TLR3 (0–20%
reduction), MDA5 (0%), RIG-I (30–50%), and PKR (30–50%)
in primary human keratinocytes (Seidl et al., 2009) and for
TLR3 (57%), MDA5 (43%), RIG-I (39%), PKR (28%), and IRF3
(59%) except for RelA (80%) in primary human bronchial
epithelial cells (Kato et al., 2007). Improvement of the
experimental conditions for transfection with dsRNA sensor
siRNAs in our system is necessary for exploring further the roles
of each of the sensors in the induction of TSLP and for
examining the roles of cytosolic sensors, the expression of which
is increased in keratinocytes of the lesions of patients with
psoriasis (Prens et al., 2008), after the stimulation-dependent
significant upregulation of their gene expression (Figure 5a).
Interestingly, TLR3 has been recently implicated in a
mechanism for the detection of skin damage and initiation of
inflammation (Lai et al., 2009) and for the detection of cell
death in the gastrointestinal epithelium (Cavassani et al., 2008),
independent of viral activation. Barrier dysfunction with
subsequent tissue damage is associated with AD (Ogawa and
Yoshiike, 1993; Palmer et al., 2006) and TSLP is overexpressed
in keratinocytes of acute and chronic skin lesions in AD
patients (Soumelis et al., 2002; Liu, 2006; Holgate, 2007).
Taken together, we speculate that self dsRNA released from
damaged tissue in the skin acts as a danger signal and triggers
TSLP production via the TLR3 pathway in keratinocytes toward
the initiation and/or exacerbation of AD.
In summary, we suggested that disruption of the TLR3–
NF-kB pathway is an effective way of shutting down dsRNA-
induced proinflammatory responses including the expression
of TSLP, the master switch for allergic inflammation, suggesting
that endosomal TLR3 rather than cytosolic sensors contributes
to at least the initial sensing of extracellular dsRNA in the
pathogenesis of skin inflammation including AD. Blocking of
pathways downstream of TSLP, such as the TSLP–TSLP receptor
interaction (He et al., 2008) and OX40L–OX40 interaction
(Seshasayee et al., 2007), has been suggested as a promising
strategy for the treatment of allergic diseases. Shutting down
the release of TSLP in the lesions of AD patients is another
straightforward strategy, which could be at least as effective as
targeting the pathways downstream of TSLP. Glucocorticoids,
known to inhibit proinflammatory gene expression dependent
on NF-kB, AP-1, and IRF3, inhibited the dsRNA-induced
proinflammatory responses including TSLP expression in
keratinocytes (Le et al., 2009, 2010) and bronchial epithelial
cells (Kato et al., 2007); however, the inhibitory effect by BFA
in keratinocytes (Figures 1, 2, and 4) seems much sharper than
that by glucocorticoids (Kato et al., 2007; Le et al., 2009,
2010). The hypothetical role of extracellular dsRNA, such as
self dsRNA released from damaged skin tissue or leaked viral
dsRNA, as a signal triggering TSLP production via TLR3 in the
pathogenesis of AD and unknown roles of the cytosolic dsRNA
sensors in the response to extracellular or cytosolic dsRNA,
independent of or dependent on viral activation, should be
investigated in future studies.
MATERIALS AND METHODS
Cell culture and stimulation of keratinocytes
Primary human keratinocytes were cultured in EpiLife KG2 (Invitrogen,
Carlsbad, CA) with supplements (Kurabo, Osaka, Japan). Cells were
cultured until 100% confluent. The medium was then changed to that
without hydrocortisone (Le et al., 2010). After further cultivation for
24hours, cells were incubated with chemical inhibitors (BFA: 100nM,
2AP: 5mM, and SU6668: 5mM in Figures 1, 2, 4a, b, and 6) in fresh
medium without hydrocortisone for 45–60minutes and stimulated by
adding medium containing poly(IC) purchased from GE Healthcare/
Amersham (Buckinghamshire, UK; 1mgml–1 in Figures 1–6 except for
Figure 4 and 1 or 20mgml–1 in Figure 4a–c), those purchased from
another manufacturer (high and low molecular weights; InvivoGen, San
Diego, CA; 20mgml–1 in Figure 4d), FSL-1, or IL-1a. Culture super-
natants for ELISA were recovered at 24–40hours after the stimulation.
For further information, see Supplementary Methods online.
ELISA and real-time quantitative PCR
Concentrations of cytokines and chemokines were measured with
ELISA kits (DuoSet; R&D Systems, Minneapolis, MN). Total RNA was
extracted from the cells and complementary DNA was synthesized as
described previously (Kinoshita et al., 2009). Real-time quantitative PCR
was performed using the Taqman method with an ABI 7500 (Applied
Biosystems, Piscataway, NJ). The mRNA level was normalized to the
gene expression of b-actin and is shown relative to the control group.
Transfection of keratinocytes with siRNA
Keratinocytes were transfected with siRNAs for RelA, IRF3, and
control siRNAs with a similar guanine-cytosine content to the
siRNAs and were stimulated with poly(IC). The expression of mRNA
relative to that in the medium was analyzed by quantitative real-time
PCR. For further information, see Supplementary Methods online.
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Flow cytometry
Keratinocytes were stimulated with poly(IC) or cultured in the absence
of poly(IC). Then, the cells were collected after being detached from the
plates and were stained for cell-surface or intracellular TLR3 expression
with phycoerythrin-conjugated anti-human TLR3 mAb or isotype control
mAb. For further information, see Supplementary Methods online.
Statistical analysis
A one-way analysis of variance with Tukey’s multiple comparison test
was used. Values of Po0.05 were regarded as statistically significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Hirokazu Kinoshita, Tuan Anh Le, and Xiao-Ling Wang for helpful
discussion or technical advice and MichiyoMatsumoto for secretarial assistance.
This work was supported in part by a grant-in-aid for Scientific Research from the
Ministry of Education, Culture, Sports, Science and Technology, Japan (to TT).
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Allakhverdi Z, Comeau MR, Jessup HK et al. (2007) Thymic stromal
lymphopoietin is released by human epithelial cells in response to
microbes, trauma, or inflammation and potently activates mast cells.
J Exp Med 204:253–8
Cavassani KA, Ishii M, Wen H et al. (2008) TLR3 is an endogenous sensor of
tissue necrosis during acute inflammatory events. J Exp Med 205:2609–21
de Bouteiller O, Merck E, Hasan UA et al. (2005) Recognition of double-
stranded RNA by human toll-like receptor 3 and downstream receptor
signaling requires multimerization and an acidic pH. J Biol Chem
280:38133–45
Ebner S, Nguyen VA, Forstner M et al. (2007) Thymic stromal lymphopoietin
converts human epidermal Langerhans cells into antigen-presenting cells
that induce proallergic T cells. J Allergy Clin Immunol 119:982–90
Godl K, Gruss OJ, Eickhoff J et al. (2005) Proteomic characterization of the
angiogenesis inhibitor SU6668 reveals multiple impacts on cellular
kinase signaling. Cancer Res 65:6919–26
He R, Oyoshi MK, Garibyan L et al. (2008) TSLP acts on infiltrating effector T
cells to drive allergic skin inflammation. Proc Natl Acad Sci USA 105:
11875–80
Holgate ST (2007) The epithelium takes centre stage in asthma and atopic
dermatitis. Trends Immunol 28:248–51
Hu Y, Conway TW (1993) 2-Aminopurine inhibits the double-stranded RNA-
dependent protein kinase both in vitro and in vivo. J Interferon Res 13:
323–8
Huss M, Wieczorek H (2009) Inhibitors of V-ATPases: old and new players.
J Exp Biol 212:341–6
Kalali BN, Kollisch G, Mages J et al. (2008) Double-stranded RNA induces an
antiviral defense status in epidermal keratinocytes through TLR3-, PKR-,
and MDA5/RIG-I-mediated differential signaling. J Immunol 181:
2694–704
Kato A, Favoreto S Jr, Avila PC et al. (2007) TLR3- and Th2 cytokine-
dependent production of thymic stromal lymphopoietin in human
airway epithelial cells. J Immunol 179:1080–7
Kinoshita H, Takai T, Le TA et al. (2009) Cytokine milieu modulates release of
thymic stromal lymphopoietin from human keratinocytes stimulated with
double-stranded RNA. J Allergy Clin Immunol 123:179–86
Lai Y, Di Nardo A, Nakatsuji T et al. (2009) Commensal bacteria regulate Toll-
like receptor 3-dependent inflammation after skin injury. Nat Med 15:
1377–82
Le TA, Takai T, Kinoshita H et al. (2009) Inhibition of double-stranded RNA-
induced TSLP in human keratinocytes by glucocorticoids. Allergy
64:1231–2
Le TA, Takai T, Vu AT et al. (2010) Glucocorticoids inhibit double-stranded
RNA-induced thymic stromal lymphopoietin release from keratinocytes
in atopic cytokine milieu more effectively than tacrolimus. Int Arch
Allergy Immunol 153:27–34
Lee HC, Ziegler SF (2007) Inducible expression of the proallergic cytokine
thymic stromal lymphopoietin in airway epithelial cells is controlled by
NFkappaB. Proc Natl Acad Sci USA 104:914–9
Liu YJ (2006) Thymic stromal lymphopoietin: master switch for allergic
inflammation. J Exp Med 203:269–73
Matsukura S, Kokubu F, Kurokawa M et al. (2006) Synthetic double-stranded
RNA induces multiple genes related to inflammation through Toll-like
receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial
cells. Clin Exp Allergy 36:1049–62
Matsukura S, Kokubu F, Kurokawa M et al. (2007) Role of RIG-I, MDA-5,
and PKR on the expression of inflammatory chemokines induced by
synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol
143(Suppl 1):80–3
Matsumoto M, Seya T (2008) TLR3: interferon induction by double-stranded
RNA including poly(I:C). Adv Drug Deliv Rev 60:805–12
McAllister CS, Samuel CE (2009) The RNA-activated protein kinase enhances
the induction of interferon-beta and apoptosis mediated by cytoplasmic
RNA sensors. J Biol Chem 284:1644–51
Ogawa H, Yoshiike T (1993) A speculative view of atopic dermatitis: barrier
dysfunction in pathogenesis. J Dermatol Sci 5:197–204
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. (2006) Common loss-of-
function variants of the epidermal barrier protein filaggrin are a major
predisposing factor for atopic dermatitis. Nat Genet 38:441–6
Pereira RM, Teixeira KL, Barreto-de-Souza V et al. (2010) Novel role for the
double-stranded RNA-activated protein kinase PKR: modulation of macro-
phage infection by the protozoan parasite Leishmania. FASEB J 24:617–26
Prens EP, Kant M, van Dijk G et al. (2008) IFN-alpha enhances poly-IC
responses in human keratinocytes by inducing expression of cytosolic
innate RNA receptors: relevance for psoriasis. J Invest Dermatol
128:932–8
Reily MM, Pantoja C, Hu X et al. (2006) The GRIP1:IRF3 interaction as a
target for glucocorticoid receptor-mediated immunosuppression. EMBO
J 25:108–17
Rochman I, Watanabe N, Arima K et al. (2007) Cutting edge: direct action of
thymic stromal lymphopoietin on activated human CD4+ T cells.
J Immunol 178:6720–4
Seidl B, Kalali B, Gerhard M et al. (2009) Thymic stromal lymphopoietin
induction by polyinosinic:polycytidylic acid in human keratinocytes is
preferentially mediated through protein kinase R and retinoid-inducible
gene I and not Toll-like receptor 3. J Allergy Clin Immunol 124:862–4
Seshasayee D, Lee WP, Zhou M et al. (2007) In vivo blockade of OX40 ligand
inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin
Invest 117:3868–78
Soumelis V, Reche PA, Kanzler H et al. (2002) Human epithelial cells trigger
dendritic cell mediated allergic inflammation by producing TSLP. Nat
Immunol 3:673–80
Takai T, Vu AT, Le TA et al. (2009) Reply. J Allergy Clin Immunol 124:864–5
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation.
Cell 140:805–20
Vu AT, Baba T, Chen X et al. (2010) Staphylococcus aureus membrane and
diacylated lipopeptide induce thymic stromal lymphopoietin in kerati-
nocytes via the Toll-like receptor 2-Toll-like receptor 6 pathway.
J Allergy Clin Immunol 126:985–93, e1–3
Wong CK, Hu S, Cheung PF et al. (2010) Thymic stromal lymphopoietin
induces chemotactic and prosurvival effects in eosinophils: implications
in allergic inflammation. Am J Respir Cell Mol Biol 43:305–15
Wu WH, Park CO, Oh SH et al. (2010) Thymic stromal lymphopoietin-
activated invariant natural killer T cells trigger an innate allergic immune
response in atopic dermatitis. J Allergy Clin Immunol 126:290–9, 9 e1–4
2212 Journal of Investigative Dermatology (2011), Volume 131
AT Vu et al.
TSLP Induction in DsRNA-Sensing Keratinocytes
